R1	Has_value Arg1:T3 Arg2:T4	
R2	Has_qualifier Arg1:T6 Arg2:T7	
R3	Has_qualifier Arg1:T9 Arg2:T11	
R4	Subsumes Arg1:T10 Arg2:T9	
R5	Has_qualifier Arg1:T13 Arg2:T15	
R6	Has_temporal Arg1:T18 Arg2:T19	
R7	Has_temporal Arg1:T23 Arg2:T22	
*	OR T17 T16
R8	AND Arg1:T23 Arg2:T17	
*	OR T23 T18
T1	Person 9 14	women
T2	Person 19 33	young children
T3	Person 34 38	aged
T4	Value 39 48	<18 years
T5	Condition 138 153	terminal cancer
T6	Condition 65 83	underlying disease
T7	Qualifier 90 130	without the possibility of resuscitation
T8	Observation 171 202	do-not-resuscitate (DNR) status
T10	Condition 205 232	Death by excessive bleeding
T9	Condition 250 269	main artery rupture
T11	Qualifier 240 249	abdominal
T13	Condition 315 317	CA
T14	Visit 306 314	hospital
T15	Qualifier 303 314	in-hospital
T16	Drug 362 382	anti-cancer medicine
T17	Drug 353 360	steroid
T18	Procedure 387 414	immunosuppression treatment
T19	Temporal 415 424	before CA
T20	Condition 422 424	CA
T21	Competing_trial 427 482	Patients already been registered with other studies; or
T22	Temporal 329 339	previously
T23	Procedure 340 347	treated
T25	Informed_consent 484 538	Patients from whom informed consent cannot be obtained
